TY - JOUR
T1 - Direct Electromembrane Extraction‐Based Mass Spectrometry: A Tool for Studying Drug Metabolism Properties of Liver Organoids
AU - Skottvoll, Frøydis Sved
AU - Aizenshtadt, Aleksandra
AU - Hansen, Frederik André
AU - Martinez, Mikel Amirola
AU - Andersen, Jannike Mørch
AU - Bogen, Inger Lise
AU - Kutter, Jörg P.
AU - Pedersen‐bjergaard, Stig
AU - Lundanes, Elsa
AU - Krauss, Stefan
AU - Wilson, Steven Ray
PY - 2022
Y1 - 2022
N2 - This work introduces a strategy for organoid analysis - direct Electromembrane Extraction based Mass Spectrometry (dEME-MS) – for coupling liver organoids with mass spectrometry (MS). dEME-MS comprises electrophoresis of selected small molecules from a culture chamber across an oil membrane, and to a MS compatible solution. This enables clean micro-extraction of drugs and their metabolites as produced in the liver organoids to capillary liquid chromatography-mass spectrometry. Applying dEME-MS, proof-of-concept of directly measuring methadone metabolism is demonstrated on adult liver organoids. With 50 liver organoids and 1 μM methadone, methadone metabolism was monitored from 0 to 24 hours (11 time points). All analytes had <0.4 % variance in retention times with >100 measurements. dEME-MS is capable of automated and selective monitoring of drug metabolism in liver organoids, and could serve as a valuable tool for automated drug discovery efforts.
AB - This work introduces a strategy for organoid analysis - direct Electromembrane Extraction based Mass Spectrometry (dEME-MS) – for coupling liver organoids with mass spectrometry (MS). dEME-MS comprises electrophoresis of selected small molecules from a culture chamber across an oil membrane, and to a MS compatible solution. This enables clean micro-extraction of drugs and their metabolites as produced in the liver organoids to capillary liquid chromatography-mass spectrometry. Applying dEME-MS, proof-of-concept of directly measuring methadone metabolism is demonstrated on adult liver organoids. With 50 liver organoids and 1 μM methadone, methadone metabolism was monitored from 0 to 24 hours (11 time points). All analytes had <0.4 % variance in retention times with >100 measurements. dEME-MS is capable of automated and selective monitoring of drug metabolism in liver organoids, and could serve as a valuable tool for automated drug discovery efforts.
U2 - 10.1002/anse.202100051
DO - 10.1002/anse.202100051
M3 - Journal article
VL - 2
JO - Analysis & Sensing
JF - Analysis & Sensing
SN - 2629-2742
IS - 2
M1 - e202100051
ER -